Skip to main navigation
Home Story Platform Pipeline People Publications Careers Investors & Press Contact
Home
/
Investor Relations
/
SEC Filing Details
Overview Press Releases Events & Presentations Financials & SEC Filings Stock Information Analyst Coverage Corporate Governance Investor FAQs Email Alerts
Investor Contacts
ir@allovir.com
Media Contacts
AlloVirPR@scientpr.com

SEC Filing Details

SEC Filing Details

Document Details

Form
10-K/A
Filing Date
Mar 30, 2022
Document Date
Dec 31, 2021
Form Description
Amendment to a previously filed 10-K
Filing Group
Annual Filings
Company
AlloVir, Inc.
Issuer
ALLOVIR, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

AlloVir is the Global Leader in Developing VST Immunotherapies

We develop highly innovative allogeneic, off-the-shelf VST therapy candidates designed to treat or prevent devastating viral infections and diseases.

Our Pipeline

Our allogeneic, off-the-shelf, VST therapy candidates target 12 different devastating viruses to treat or prevent life-threatening viral diseases.
view

Our Platform

Our proprietary platform develops allogeneic, off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies.
learn

Our People

Our founders have a singular vision: to serve patients at risk of the devastating consequences of severe viral infections and diseases.
meet
Allovir Logo

Waltham

1100 Winter Street
Waltham, MA 02451

Houston

2925 Richmond Ave
Suite 1200
Houston, TX 77098

Company

About Us Contact Us 617-433-2605
Contact Careers
AlloVir, Inc. ©2023 All rights reserved

You are now leaving AlloVir’s website.

AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
yes no

You are now leaving AlloVir’s website.

AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
yes no